Skeletal muscle immunohistochemistry of acquired and hereditary myopathies.
Curr Opin Rheumatol
; 33(6): 529-536, 2021 11 01.
Article
em En
| MEDLINE
| ID: mdl-34431810
ABSTRACT
PURPOSE OF REVIEW The continued development in the field of immunohistochemistry (IHC) has improved the ability to diagnose muscle diseases. Many hereditary diseases are diagnosed by the absence or abnormal localization of proteins. Detection of secondary pathological protein expression is also used in diagnostics, and to study disease processes. We relate and discuss recent reports, where IHC has been an important tool in the investigation of muscle diseases. RECENT FINDINGS:
In idiopathic inflammatory myopathies, IHC has extended its role to diagnose subgroups. This is most evident concerning immune-mediated necrotizing myopathy and antisynthetase syndrome. The availability of new antibodies has increased the sensitivity of a muscle biopsy to diagnose several hereditary myopathies. The introduction of protein restoration therapies in muscular dystrophies also comes with the need to detect and measure protein levels. For the study of disease processes at the protein level, in both acquired and hereditary myopathies IHC, often combined with gene studies, PCR-based methods, western blotting and electron microscopy, continues to bring forth interesting results.SUMMARY:
IHC is an integrated tool in muscle pathology, where recent studies contribute to improved diagnostic skills and increased insights into disease processes.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Doenças Musculares
/
Distrofias Musculares
/
Miosite
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article